Thus, our findings indicated that exogenous GLP-2 and massive distal bowel resection exert disparate intestinal and extra-intestinal manifestations that modulate body composition over the short-term with clinical implications for patients with SBS. This evidence concerns the gene GCG and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.